Patient Centricity

Patients always at heart.

A recent report released by The Economist Intelligence Unit (EIU)1 and commissioned by us confirmed what we’ve known for years – that drugs developed with patients at heart are more likely to launch.

Throughout our years helping discoveries come to market, one thing has remained constant – the more patient-focused the process, the better. That’s why all our services take patient input to heart before, during and after a clinical study.

PC chart for website.png

Source: The Innovation Imperative: The Future of Drug Development, The Economist Intelligence Unit, 2018.

 

Patient-centricity at every point

Pre-Study:
  • We design protocols to identify and address potential practical barriers to study participation
  • We use a combination of web listening, patient, caregiver, and site staff input to get a clear picture of the patient burdens to best care for volunteers through recruitment and retention
  • We proactively seek opportunities to address the needs of commercial stakeholders and build a better value story
  • Our regulatory experts incorporate guidance to address agency requirements from a patient-centric perspective
During Study:
  • To make the process as easy as possible for patients, we can help with eConsent, home nursing, direct-to-patient drug shipments, patient apps, and video dosing
  • Our Patient Sensor Solution allows for continuous data collection with wearables to remotely capture, transmit, and store data in a secure platform
Market Access and Beyond
  • We can help patients understand study outcomes and ways to transition to a post-study treatment plan
  • To get needed therapies to market as quickly as possible, we identify and develop ways to speed up market access
  • Through our Managed Access Programs we facilitate early access to promising new medicines for patients with unmet needs 
  • PC capture.PNG


 

We are always available for a conversation.

*